Protalix BioTherapeutics (PLX) Non-Current Debt (2011 - 2017)

Protalix BioTherapeutics' Non-Current Debt history runs 6 years deep, the most recent figure standing at $4.3 million for Q3 2017.

• In Q3 2017, Non-Current Debt changed 0.0% year-over-year to $4.3 million; the TTM figure through Sep 2017 stood at $4.3 million (changed 0.0% YoY), while the FY2016 annual figure was $4.3 million, changed 0.0% from the prior year.
• Non-Current Debt was $4.3 million for Q3 2017 at Protalix BioTherapeutics, roughly flat from $4.3 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $4.3 million in Q4 2015 to a low of $376000.0 in Q2 2013.
• Historically, Non-Current Debt has averaged $3.6 million across 4 years, with a median of $4.3 million in 2015.
• The sharpest annual moves came in 2013 and 2016: Non-Current Debt slumped 91.97% in 2013, then changed 0.0% in 2016.
• A 4-year view of Non-Current Debt shows it stood at $2.4 million in 2013, then soared by 81.4% to $4.3 million in 2015, then changed by 0.0% to $4.3 million in 2016, then changed by 0.0% to $4.3 million in 2017.
• The last three Non-Current Debt figures came in at $4.3 million (Q3 2017), $4.3 million (Q2 2017), and $4.3 million (Q1 2017), per Business Quant data.